SCHEMBL7690746

SCHEMBL7690746

CCCCC(NC(=O)c1ccccc1C=Cc1ccc(OC)c(OC)c1)C(=O)CNS(=O)(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 7/20 0.56
CTSB P07858 5/20 0.49
CTSL P07711 2/20 0.41
CNR2 P34972 1/20 0.40
ALDH1A1 P00352 4/20 0.39
CTSS P25774 2/20 0.39
CTSK P43235 2/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP1A1 P04798 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP1B1 Q16678 1/20 0.39
KDM4E B2RXH2 2/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
PKM P14618 2/20 0.38
GAA P10253 1/20 0.38
KEAP1 Q14145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695839 0.89 CAPN1 (0.70) CAPN1CTSBCTSLCNR2ALDH1A1
SCHEMBL7695233 0.88 CAPN1 (0.54) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7693291 0.88 CAPN1 (0.52) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7689853 0.86 CAPN1 (0.59) CAPN1CTSBCTSLCNR2ALDH1A1
SCHEMBL7697828 0.86 CAPN1 (0.59) CAPN1CTSBCTSLCNR2ALDH1A1
SCHEMBL7690894 0.86 CAPN1 (0.58) CAPN1CTSBCTSLCNR2ALDH1A1
SCHEMBL7696610 0.86 CAPN1 (0.58) CAPN1CTSBCTSLCNR2ALDH1A1
SCHEMBL7695407 0.84 CTSB (0.50) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7692161 0.83 CAPN1 (0.70) CAPN1CTSBCTSLCTSSCTSK
SCHEMBL7697236 0.81 CAPN1 (0.51) CAPN1CTSBCTSLALDH1A1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed